LifeStance Health Group (LFST) Stock Price, News & Analysis

Company Overview

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations.

LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services.

Key Stats

• Today's Range: $5.16 to $5.47
• 50-Day Range: $3.79 to $5.63
• 52-Week Range: $3.74 to $8.61
• Volume: 1.37 million shs
• Average Volume: 2.02 million shs
• Market Capitalization: $2.02 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $8.50
• Consensus Rating: Moderate Buy

LifeStance Health Group Stock Analysis - MarketRank™

LifeStance Health Group scored higher than 71% of companies evaluated by MarketBeat, and ranked 282nd out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

LifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.86, and is based on 5 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

LifeStance Health Group has a consensus price target of $8.50, representing about 63.9% upside from its current price of $5.19.

Amount of Analyst Coverage

LifeStance Health Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for LifeStance Health Group are expected to grow in the coming year, from ($0.18) to ($0.14) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of LifeStance Health Group is -103.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of LifeStance Health Group is -103.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

LifeStance Health Group has a P/B Ratio of 1.37. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.75% of the float of LifeStance Health Group has been sold short.

Short Interest Ratio / Days to Cover

LifeStance Health Group has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in LifeStance Health Group has recently decreased by 0.13%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

LifeStance Health Group does not currently pay a dividend.

Dividend Growth

LifeStance Health Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

4.75% of the float of LifeStance Health Group has been sold short.

Short Interest Ratio / Days to Cover

LifeStance Health Group has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in LifeStance Health Group has recently decreased by 0.13%, indicating that investor sentiment is improving.

News and Social Media

• Score: 4.0 / 5
• News Sentiment: 1.28

News Sentiment

LifeStance Health Group has a news sentiment score of 1.28. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.84 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for LifeStance Health Group this week, compared to 4 articles on an average week.

Search Interest

11 people have searched for LFST on MarketBeat in the last 30 days. This is an increase of 120% compared to the previous 30 days.

MarketBeat Follows

1 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $103,466,750.00 in company stock.

Percentage Held by Insiders

Only 6.60% of the stock of LifeStance Health Group is held by insiders.

Percentage Held by Institutions

85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

LFST Stock Analysis - Frequently Asked Questions

How have LFST shares performed this year?

LifeStance Health Group's stock was trading at $7.37 at the start of the year. Since then, LFST shares have decreased by 29.6% and is now trading at $5.1850.

How were LifeStance Health Group's earnings last quarter?

LifeStance Health Group, Inc. (NASDAQ:LFST) issued its earnings results on Thursday, August, 7th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.02. LifeStance Health Group's revenue was up 10.6% on a year-over-year basis.
Read the conference call transcript.

When did LifeStance Health Group IPO?

LifeStance Health Group (LFST) raised $640 million in an initial public offering on Thursday, June 10th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

Who are LifeStance Health Group's major shareholders?

LifeStance Health Group's top institutional investors include Jennison Associates LLC (1.87%), Brown Advisory Inc. (1.34%), Geode Capital Management LLC (0.87%) and Qube Research & Technologies Ltd (0.63%). Insiders that own company stock include Summit Partners Growth Equity, Darren M Black, Summit Partners L P, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Robert Bessler, Ryan Pardo, Danish J Qureshi, David Bourdon, Lisa K Miller, Anisha Patel-Dunn, Ann Varanakis, Paula Cipollone and Ujjwal Ramtekkar.
View institutional ownership trends.

How do I buy shares of LifeStance Health Group?

Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of LifeStance Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Last Earnings: 8/07/2025
• Today: 9/10/2025
• Next Earnings (Estimated): 11/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:LFST
• CIK: 1845257
• Web: www.lifestance.com
• Phone: 602-767-2100
• Fax: N/A
• Employees: 10,218
• Year Founded: N/A

Price Target and Rating

• Average Price Target for LifeStance Health Group: $8.50
• High Price Target: $10.00
• Low Price Target: $7.00
• Potential Upside/Downside: +54.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.86
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.05)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$57.44 million
• Net Margins: -1.23%
• Pretax Margin: -1.65%
• Return on Equity: -1.11%
• Return on Assets: -0.76%

Debt

• Debt-to-Equity Ratio: 0.19
• Current Ratio: 1.48
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $1.25 billion
• Price / Sales: 1.71
• Cash Flow: $0.04 per share
• Price / Cash Flow: 141.48
• Book Value: $3.78 per share
• Price / Book: 1.45

Miscellaneous

• Outstanding Shares: 388,940,000
• Free Float: 363,266,000
• Market Cap: $2.14 billion
• Optionable: Optionable
• Beta: 1.17